Monthly Archives: November 2021

Q&A with Mark Berger, M.D., Genprex’s Chief Medical Officer

Dr. Mark Berger is a senior executive with 25 years of biotech and pharmaceutical company experience in the development of oncology therapeutics.

Read More

Genprex to Present in November CEO Roadshow Webinar

Presentation to highlight Genprex’s novel gene therapy pipeline in cancer and diabetes

Read More